76 related articles for article (PubMed ID: 17542507)
1. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
Rajpal S; Gerovac TA; Turner NA; Tilghman JI; Allcock BK; McChesney SL; Miranpuri GS; Park SW; Resnick DK
J Neurosurg Spine; 2007 May; 6(5):420-4. PubMed ID: 17542507
[TBL] [Abstract][Full Text] [Related]
2. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury.
DomBourian MG; Turner NA; Gerovac TA; Vemuganti R; Miranpuri GS; Türeyen K; Satriotomo I; Miletic V; Resnick DK
Spine (Phila Pa 1976); 2006 Nov; 31(24):2778-82. PubMed ID: 17108828
[TBL] [Abstract][Full Text] [Related]
3. Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath.
Tékus V; Bölcskei K; Kis-Varga A; Dézsi L; Szentirmay E; Visegrády A; Horváth C; Szolcsányi J; Petho G
Eur J Pharmacol; 2010 Sep; 641(2-3):135-41. PubMed ID: 20534382
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the peripheral mediator background of heat injury- and plantar incision-induced drop of the noxious heat threshold in the rat.
Füredi R; Bölcskei K; Szolcsányi J; Petho G
Life Sci; 2010 Feb; 86(7-8):244-50. PubMed ID: 20036261
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.
Kamata Y; Kambe T; Chiba T; Yamamoto K; Kawakami K; Abe K; Taguchi K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570786
[TBL] [Abstract][Full Text] [Related]
6. The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli.
Davis AJ; Kelly D; Perkins MN
Braz J Med Biol Res; 1994 Aug; 27(8):1793-802. PubMed ID: 7749369
[TBL] [Abstract][Full Text] [Related]
7. Lys-[Leu8,des-Arg9]-bradykinin blocks lipopolysaccharide-induced SHR aorta hyperpolarization by inhibition of Ca(++)- and ATP-dependent K+ channels.
Farias NC; Feres T; Paiva AC; Paiva TB
Eur J Pharmacol; 2004 Sep; 498(1-3):163-9. PubMed ID: 15363991
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transient receptor potential vanilloid-1 confers neuroprotection, reduces tumor necrosis factor-alpha, and increases IL-10 in a rat stroke model.
Hakimizadeh E; Shamsizadeh A; Roohbakhsh A; Arababadi MK; Hajizadeh MR; Shariati M; Rahmani MR; Allahtavakoli M
Fundam Clin Pharmacol; 2017 Aug; 31(4):420-428. PubMed ID: 28199737
[TBL] [Abstract][Full Text] [Related]
9. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
Gavva NR; Tamir R; Qu Y; Klionsky L; Zhang TJ; Immke D; Wang J; Zhu D; Vanderah TW; Porreca F; Doherty EM; Norman MH; Wild KD; Bannon AW; Louis JC; Treanor JJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):474-84. PubMed ID: 15615864
[TBL] [Abstract][Full Text] [Related]
10. Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Oh SB; Lee JH
Mol Pain; 2014 Jan; 10():2. PubMed ID: 24401144
[TBL] [Abstract][Full Text] [Related]
11. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
12. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-dependent K+ channels are targets for bradykinin B1 receptor ligands and for lipopolysaccharide in the rat aorta.
Farias NC; Feres T; Paiva AC; Paiva TB
Eur J Pharmacol; 2005 Nov; 525(1-3):123-7. PubMed ID: 16269143
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
Drapeau G; deBlois D; Marceau F
J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
[TBL] [Abstract][Full Text] [Related]
16. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
17. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
18. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.
Gavva NR; Bannon AW; Surapaneni S; Hovland DN; Lehto SG; Gore A; Juan T; Deng H; Han B; Klionsky L; Kuang R; Le A; Tamir R; Wang J; Youngblood B; Zhu D; Norman MH; Magal E; Treanor JJ; Louis JC
J Neurosci; 2007 Mar; 27(13):3366-74. PubMed ID: 17392452
[TBL] [Abstract][Full Text] [Related]
19. Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
Beider K; Rosenberg E; Dimenshtein-Voevoda V; Sirovsky Y; Vladimirsky J; Magen H; Ostrovsky O; Shimoni A; Bromberg Z; Weiss L; Peled A; Nagler A
J Hematol Oncol; 2020 Nov; 13(1):158. PubMed ID: 33239060
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain.
Hama A; Sagen J
J Neurotrauma; 2011 Jan; 28(1):127-34. PubMed ID: 20954888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
